In summary, our research revealed that HMGCR inhibition induced the enhancement of glycolysis in tumors, thus suggesting that this is the mechanism responsible for reduced cholesterol synthesis during the development of RCC. This evidence concerns the gene HMGCR and renal cell carcinoma.